GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MindMaze Therapeutics Holding MMTX.SW · CHF

Health Care · SIX · 🇨🇭 Switzerland

Compare

0.14

+0.89%

Close of 9 Nov 2026, in CHF

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CHF, from our data supplier.

FY2025

Revenue

CHF 642,000

FY2016FY2025

Net income

−CHF 9.9m

FY2016FY2025

Free cash flow

−CHF 7.2m

FY2016FY2025

Shareholders' equity

CHF 38.3m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCHF 642,000—CHF 6.0mCHF 6.1mCHF 3.3m——CHF 565,000—CHF 15,000
Research and developmentCHF 5.3m—CHF 1.3mCHF 12.4mCHF 19.0mCHF 13.7mCHF 68,000CHF 55,000CHF 71,000CHF 211,000
Operating income−CHF 10.5m−CHF 2,000−CHF 19.5m−CHF 25.6m−CHF 33.6m−CHF 20.3m−CHF 862,000−CHF 500,000−CHF 1.7m−CHF 1.9m
Net income−CHF 9.9m−CHF 1,000−CHF 98.2m−CHF 50.8m−CHF 34.7m−CHF 7.8m−CHF 7.5m−CHF 436,000−CHF 2.9m−CHF 16.8m
Diluted earnings per share-0.06-0.00-8.35-4.81-3.86-1.30-0.00-0.00-0.00-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCHF 51.5mCHF 93,000CHF 76.4mCHF 188.8mCHF 251.6mCHF 78.0mCHF 19.9mCHF 35.6mCHF 31.0mCHF 31.4m
Cash and short-term investments——CHF 14.6mCHF 19.2mCHF 44.8mCHF 38.2mCHF 129,000CHF 265,000CHF 135,000CHF 394,000
Total liabilitiesCHF 13.2mCHF 7,000CHF 24.2mCHF 43.4mCHF 70.1mCHF 11.0mCHF 5.6mCHF 14.3mCHF 10.0mCHF 9.2m
Debt——CHF 4.3mCHF 4.3mCHF 4.3mCHF 891,000CHF 1.7mCHF 1.1mCHF 1.0mCHF 878,000
Shareholders' equityCHF 38.3mCHF 86,000CHF 52.2mCHF 145.4mCHF 181.5mCHF 67.0mCHF 14.3mCHF 21.3mCHF 20.9mCHF 22.2m
Shares outstanding153m170m12m11m9m6m2,104m2,050m1,988m1,266m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−CHF 7.2m−CHF 3,000−CHF 17.6m−CHF 24.1m−CHF 35.7m−CHF 18.3m−CHF 728,000−CHF 618,000−CHF 1.2m−CHF 2.9m
Capital spending−CHF 22,000—−CHF 446,000−CHF 521,000−CHF 13.7m————−CHF 11,000
Free cash flow−CHF 7.2m−CHF 3,000−CHF 18.1m−CHF 24.6m−CHF 49.4m−CHF 18.3m−CHF 728,000−CHF 618,000−CHF 1.2m−CHF 2.9m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueCHF 1.2mCHF 2.8mCHF 5.6mCHF 3.0mCHF 3.0mCHF 2.8mCHF 3.2mCHF 3.3m
Operating income−CHF 4.4m−CHF 2.6m−CHF 4.0m−CHF 8.0m−CHF 11.5m−CHF 6.6m−CHF 19.0m−CHF 19.5m
Net income−CHF 4.5m−CHF 12.6m−CHF 4.6m−CHF 41.7m−CHF 56.5m−CHF 24.3m−CHF 26.5m−CHF 20.0m
Diluted earnings per share-0.36-1.00-0.36-3.36-5.10-2.26-2.55-2.08
Cash from operations−CHF 3.0m—−CHF 3.0m−CHF 7.0m−CHF 10.0m−CHF 9.0m−CHF 14.0m−CHF 17.0m
Total assetsCHF 48.0mCHF 53.2mCHF 70.9mCHF 76.4mCHF 125.8mCHF 188.8mCHF 221.8mCHF 251.6m
Cash and short-term investmentsCHF 12.5mCHF 15.1mCHF 10.7mCHF 14.6mCHF 12.8mCHF 19.2mCHF 29.9mCHF 44.8m
DebtCHF 1.5mCHF 1.7mCHF 2.0mCHF 3.5mCHF 3.7mCHF 3.5mCHF 3.7mCHF 3.8m
Shareholders' equityCHF 32.6mCHF 36.7mCHF 49.3mCHF 52.2mCHF 94.4mCHF 145.4mCHF 161.4mCHF 181.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-52.7%——
Operating income-25.7%-12.3%62.7%
Net income-42.0%4.8%61.7%

Valuation history

At each fiscal year end

FY2025
Price to earnings-29.3
Price to sales451.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 400-to-1 reverse split · 5 May 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.